INDOCYANINE GREEN
IJB-IFIBC-2022/01
Phase 2 small_molecule active
Quick answer
INDOCYANINE GREEN for Patients with primary invasive early breast cancer (T1-T2) that will undergo planned breast-conserving surgery is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Patients with primary invasive early breast cancer (T1-T2) that will undergo planned breast-conserving surgery
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active